HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nader Fotouhi Selected Research

Leukotriene B4 Receptors (Leukotriene B4 Receptor)

6/2010Effects of LTB4 receptor antagonism on pulmonary inflammation in rodents and non-human primates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nader Fotouhi Research Topics

Disease

11Tuberculosis (Tuberculoses)
02/2024 - 01/2019
6Neoplasms (Cancer)
03/2024 - 02/2004
4Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2023 - 01/2021
4Infections
10/2022 - 01/2019
2Extensively Drug-Resistant Tuberculosis
02/2024 - 11/2021
1Persistent Infection
10/2023
1Granuloma
01/2023
1Bacteremia
10/2022
1Wound Infection (Wound Infections)
10/2022
1Staphylococcal Infections
10/2022
1Inflammation (Inflammations)
06/2010
1Pneumonia (Pneumonitis)
06/2010
1Pulmonary Eosinophilia (Eosinophilic Pneumonia)
06/2010
1Asthma (Bronchial Asthma)
06/2010
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
06/2010
1Chronic Obstructive Pulmonary Disease (COPD)
06/2010
1Acute Lung Injury
06/2010

Drug/Important Bio-Agent (IBA)

6Linezolid (Zyvox)FDA Link
02/2024 - 01/2019
6pretomanidIBA
02/2024 - 01/2019
6bedaquiline (R207910)IBA
02/2024 - 01/2019
3DiarylquinolinesIBA
01/2023 - 01/2021
2Heme Oxygenase-1IBA
12/2023 - 11/2023
2MetalloporphyrinsIBA
12/2023 - 11/2023
2tin mesoporphyrinIBA
12/2023 - 11/2023
2Antitubercular AgentsIBA
10/2023 - 01/2022
2TBAJ-876IBA
01/2023 - 11/2021
2Oxazolidinones (2 Oxazolidone)IBA
01/2023 - 10/2022
2Moxifloxacin (Avelox)FDA Link
01/2021 - 01/2019
2PyrazinamideFDA LinkGeneric
01/2021 - 01/2019
2Mitogen-Activated Protein KinasesIBA
01/2010 - 03/2009
1raltitrexed (D 1694)IBA
03/2024
1Thymidylate SynthaseIBA
03/2024
1phosphopantetheinyl transferaseIBA
03/2024
1contezolidIBA
12/2023
1CytochromesIBA
10/2023
1duroquinol oxidaseIBA
10/2023
1Oxidoreductases (Dehydrogenase)IBA
10/2023
1Anti-Bacterial Agents (Antibiotics)IBA
10/2022
1PlacebosIBA
10/2022
1Lysine-tRNA LigaseIBA
10/2022
1Drug CombinationsIBA
01/2022
1Mechanistic Target of Rapamycin Complex 2IBA
01/2021
1Mechanistic Target of Rapamycin Complex 1IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
09/2013
1Peptides (Polypeptides)IBA
09/2013
1ATSP-7041IBA
09/2013
1Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA
06/2010
14- (3- (6- (3- benzo(1,3)dioxol- 5- yl- 5- thiophen- 3- ylphenoxy)hexyl)- 2- (2- carboxyethyl)phenoxy)butyric acidIBA
06/2010
1Leukotriene B4IBA
06/2010
1Phosphotransferases (Kinase)IBA
01/2010
12- (4- (4- (2,3- dihydroxy- propoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- N- (2- fluoro- 4- iodo- phenyl)- 3- phenylbutyramideIBA
01/2010
1MAP Kinase Kinase 1IBA
03/2009
1(2S,3S)- 2- ((R)- 4- (4- (2- hydroxyethoxy)phenyl)- 2,5- dioxo- imidazolidin- 1- yl)- 3- phenyl- N- (4- propionylthiazol- 2- yl)butyramideIBA
03/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2009
1AgarIBA
02/2008
1Small Interfering RNA (siRNA)IBA
02/2008
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
02/2008
1Antineoplastic Agents (Antineoplastics)IBA
02/2008

Therapy/Procedure

4Therapeutics
01/2021 - 02/2004
2Duration of Therapy
01/2022 - 01/2019
1Secondary Prevention
01/2023